Eisai Inc. Announces the Appointment of Dr. Janna Hutz as President of the Eisai Center for Genetics Guided Dementia Discovery
- Thursday, August 5, 2021, 7:13
- Finance
- Add a comment
WOODCLIFF LAKE, N.J., Aug. 5, 2021 /PRNewswire/ — Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the appointment of Janna Hutz, Ph.D., as President of the Eisai Center for Genetics Guided Dementia Discovery (G2D2). In this role, Dr. Hutz oversees the…
About the Author
adminasapcorp has written 39391 stories on this site.